机译:Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency
Department of Clinical Immunology Royal Free London NHS Foundation Trust;
Department of Immunology and Gene Therapy Great Ormond Street Hospital for Children NHS Trust;
Institute for Immunodeficiency Center for Chronic Immunodeficiency (CCI) Faculty of MedicineResearch Unit for Pediatric Hematology and Immunology Division of Pediatric Hematology-OncologyDepartment of Pediatrics Stem Cell Transplantation Program Willem-Alexander Children's HospitalInstitute for Immunity and Transplantation University College LondonTranslational and Clinical Research Institute Newcastle University and Pediatric Immunology + HSCTHUS Rare Disease Center Children and Adolescents University of Helsinki and Helsinki University;
adult; conservative treatment; HLH; HSCT; IBD; phenotype; primary immunodeficiency; survival outcomes; therapy; X-linked inhibitor of apoptosis; XIAP deficiency;